
Dr. Douglas Carnes
Founder and Chief Executive Officer, was the founder and CEO of Carnes Communications Inc (CCI), a Medical Education organization, providing CME education to medical professionals at healthcare conferences. Prior to the sale of CCI in 1996, it maintained 125 employees with $25M in annual revenue. Prior to CCI, Dr. Carnes spent 13 years with Smith Kline & French (SK&F) in marketing and sales. Dr. Carnes currently serves on two Board of Directors in various positions.
Dr. Ryan N. Fiorini
Founder and Chief Operating Officer, received his Ph.D. in Microbiology and Immunology, focusing much of his thesis work on the therapeutic use of monoclonal antibodies in
septic transplant patients. In addition to his scientific background in the antibody field,
Dr. Fiorini received his MBA and Masters in Health Administration (MHA), giving him a well rounded scientific and business background. Dr. Fiorini's focus for the company includes, business development, day-to-day operations of the laboratory and expanding opportunities to apply the technology platform.
Lloyd A. Pearson
Executive Vice President and Chief Financial Officer, is the principal for a group of companies affiliated with Horizon Management, LLC, that invest in real estate, distribution and evolving technology companies. He began his career as a CPA with a national accounting firm and has served as Senior VP of Operations and Business Development with Cameron & Barkley and as CFO of Coburg Dairy. Both of these companies were sold to international publicly traded companies after experiencing significant growth during Mr. Pearson’s tenure. He also helped found a software company that specializes in warehousing and distribution logistics and is actively involved in ESOP company conversions.